Papers/PMID:26678256
Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.
The Cochrane database of systematic reviews2015The record
1 finding · 1 compound · 1 endpoint
What it reported
How to read these marksWhat moved
1 finding
myo-inositol — decreases gestational diabetes mellitus incidence
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“For the mother, supplementation with myo-inositol was associated with a reduction in the incidence of gestational diabetes compared with control (risk ratio (RR) 0.43, 95% confidence interval (CI) 0.29 to 0.64; three trials; n = 502 women).”
Quoted verbatim from Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.. - Study
- meta-analysis
- Participants
- 502
- Population
- Pregnant women without pre-existing diabetes, pooled from three randomised trials conducted in Italy
Effect 0.43 risk ratio, 95% CI 0.29 to 0.64
Antenatal dietary supplementation with myo-inositol in women during pregnancy for preventing gestational diabetes.2015PMID:26678256Permalink